DaVita Inc. (DVA)
NYSE: DVA · Real-Time Price · USD
144.43
+0.67 (0.47%)
At close: May 12, 2025, 4:00 PM
143.89
-0.54 (-0.37%)
After-hours: May 12, 2025, 7:59 PM EDT
DaVita Employees
DaVita had 76,000 employees as of December 31, 2024. The number of employees increased by 6,000 or 8.57% compared to the previous year.
Employees
76,000
Change (1Y)
6,000
Growth (1Y)
8.57%
Revenue / Employee
$170,638
Profits / Employee
$11,311
Market Cap
11.10B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 76,000 | 6,000 | 8.57% |
Dec 31, 2023 | 70,000 | 0 | - |
Dec 31, 2022 | 70,000 | 1,000 | 1.45% |
Dec 31, 2021 | 69,000 | 2,000 | 2.99% |
Dec 31, 2020 | 67,000 | 2,000 | 3.08% |
Dec 31, 2019 | 65,000 | -12,700 | -16.34% |
Dec 31, 2018 | 77,700 | 3,200 | 4.30% |
Dec 31, 2017 | 74,500 | 4,200 | 5.97% |
Dec 31, 2016 | 70,300 | 9,900 | 16.39% |
Dec 31, 2015 | 60,400 | 2,500 | 4.32% |
Dec 31, 2014 | 57,900 | 500 | 0.87% |
Dec 31, 2013 | 57,400 | 4,000 | 7.49% |
Dec 31, 2012 | 53,400 | 12,400 | 30.24% |
Dec 31, 2011 | 41,000 | 4,500 | 12.33% |
Dec 31, 2010 | 36,500 | 2,500 | 7.35% |
Dec 31, 2009 | 34,000 | 1,500 | 4.62% |
Dec 31, 2008 | 32,500 | 1,500 | 4.84% |
Dec 31, 2007 | 31,000 | 2,100 | 7.27% |
Dec 31, 2006 | 28,900 | 900 | 3.21% |
Dec 31, 2005 | 28,000 | 12,700 | 83.01% |
Dec 31, 2004 | 15,300 | 1,500 | 10.87% |
Dec 31, 2003 | 13,800 | 800 | 6.15% |
Dec 31, 2002 | 13,000 | 300 | 2.36% |
Dec 31, 2001 | 12,700 | 500 | 4.10% |
Dec 31, 2000 | 12,200 | -100 | -0.81% |
Dec 31, 1999 | 12,300 | 0 | - |
Dec 31, 1998 | 12,300 | 3,470 | 39.30% |
Dec 31, 1997 | 8,830 | 5,705 | 182.56% |
Dec 31, 1996 | 3,125 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
DVA News
- 3 hours ago - DaVita Inc. (DVA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 hours ago - DaVita beats quarterly profit estimates amid stable demand for dialysis services - Reuters
- 8 hours ago - DaVita First-Quarter 2025 Financial Results: Just the Numbers - Investopedia
- 8 hours ago - DaVita Inc. 1st Quarter 2025 Results - PRNewsWire
- 12 days ago - DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call - PRNewsWire
- 4 weeks ago - DaVita Says Ransomware Attack Affecting Some Operations - WSJ
- 4 weeks ago - Dialysis firm DaVita hit by ransomware attack - Reuters
- 6 weeks ago - These 15 stocks are the most profitable companies in the S&P 500 - Market Watch